![Logo der Firma Immunic AG](http://cdn.pressebox.de/f/f790d90b6c75530a/logos/173149/500_500.gif)
Immunic enters into a global option and license agreement with Daiichi Sankyo
Immunic AG gains exclusive, worldwide rights to promising drug development program with novel target for treatment of in…
Immunic AG gains exclusive, worldwide rights to promising drug development program with novel target for treatment of in…
Market Scenario The Transthyretin (TTR) amyloidosis market is expected to register a sturdy growth during the forecast…
Market Scenario for Global Anti-Hypertensive Drugs Market: Anti-hypertensive drugs are used to treat hypertension (hig…
Market Scenario: Fibromuscular dysplasia (FMD) is a disease that causes abnormal cell development in the artery wall,…
Market Scenario The cardiopulmonary disease is used to describe a wide range of series of disorders which affect the h…
Market Scenario Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals d…
Die kanadischen Biotech-Profis von Aequus Pharmaceuticals Inc. (ISIN: CA0076361033 / TSX-V: AQS) stimmt den von Sandoz n…
Die kanadischen Biotech-Profis von Aequus Pharmaceuticals Inc. (ISIN: CA0076361033 / TSX-V: AQS) stimmt den von Sandoz n…
Owing to non-responsive nature of several advance pharmacotherapies and high diagnosis and treatment costs, researchers…
Das Jahr 2017 war sehr erfolgreich für das kanadische Biotechnologieunternehmen Aequus Pharmaceuticals (ISIN: CA0076361…